Advanced Search

Hematologic Transplantation & Transfusion Evaluations

To view Evaluated Articles, you must have an active subscription (or trial) and be signed in.
If you have an active subscription (or trial), please sign in. If your access has expired, you can subscribe at $9.95 per month. If you think you should be able to access this content, please contact us.

Sign in | Free Trial | Subscribe | Recommend to Library

New to F1000? See the Top Rated article below for a free preview of one of our Evaluated Articles.

SECTION HEADS

  • Photo of Jay Menitove

    Jay Menitove

    Blood Bank & Transfusion Medicine Department, Community Blood Center of Greater Kansas City, Kansas City, MO, USA

  • Photo of Paolo Rebulla

    Paolo Rebulla

    Center of Transfusion Medicine, Cellular Therapy and Cryobiology, Department of Regenerative Medicine, Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Milan, Italy

  • Photo of Norbert Schmitz

    Norbert Schmitz

    Department of Hematology, AK St Georg, Hamburg, Germany

Section Topics

  • » Acute leukemias
  • » Adverse reactions to transfusion (hemolytic, febrile TRALI, septic, allergic)
  • » Aplastic anemia
  • » Autoimmune diseases
  • » Blood components (preparation & new products)
  • » Blood donors (selection, donation & testing)
  • » Blood transfusion in surgery/anesthesiology & obstetrics
  • » Cell therapy, stem cell/bone marrow collections & processing
  • » Chronic leukemias
  • » Clinical use of blood products, transfusion procedures & administration of blood
  • » Clinical use of plasma & immunoglobulins
  • » Hemoglobin-based oxygen carriers (HBOC)
  • » Immune deficiencies
  • » Infections transmissible by transfusion
  • » Lymphoma
  • » Matching techniques & complications
  • » Myeloma
  • » Pediatric transfusion practice
  • » Plasma derivatives (preparation & new products)
  • » Post -transplant complications
  • » Post-transplantation quality of life
  • » Red cell compatibility & pretransfusion testing
  • » Solid tumors
  • » Therapeutic plasma exchange & therapeutic cytapheresis
  • » Transfusion in newborns & hemolytic disease of newborn
  • » Transfusion informatics

LATEST EVALUATION

This article offers new therapeutic options for the life-threatening complication of stem cell transplantation: graft-versus-host disease (GvHD). Thus, this article may initiate further studies leading to the establishment of this therapy.

Mark Berneburg and Lena Krieger, Eberhard Karls University, Germany. F1000 Dermatology

6 Recommended

TOP RATED ARTICLE THIS WEEK [FREE TO VIEW]

9
Interleukin-2 and regulatory T cells in graft-versus-host disease.

Koreth J, Matsuoka K, Kim HT, McDonough SM, ..., Avigan DE, Antin JH, Ritz J, Soiffer RJ. N Engl J Med. 2011 Dec 1; 365(22):2055-66

2 Evaluations, most recent by

Lars Rogge, Institut Pasteur, Department of Immunology, France. F1000 Rheumatology & Clinical Immunology

  • New Finding
  • Clinical Trial

INDIVIDUALS

Get instant access to evaluations from over 10,000 experts in biology and medicine by taking a free trial or an individual subscription.

Get a FREE Trial Subscribe for $9.95 per month

Already have a subscription? Sign in for instant access. If you are signed in but are not able to view content, your access has expired. Please take out a subscription or recommend F1000 to your librarian.

RECOMMENDATIONS

Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.

Recommend to your Librarian

LIBRARIANS & INFORMATION MANAGERS

Get an extended free trial supporting clinicians and researchers at your academic or corporate institution.

Request an Institutional Trial

FREE ACCESS

Your institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.

Faculty of 1000